EPO: Clinical Trials

5 trials of EPO, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Recruiting 1

Follow EPO: new trials by email Literature Review of EPO trials Research Report on EPO

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial
Iron, EPO, 0.9 % NaCl - Anemia, Sepsis
Phase 4RecruitingPiotr Czempik2002024-11-102024-12-27
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
Erythropoietin - Liver Transplant Rejection
Phase 4CompletedNorthwestern University92022-02-182026-10-29
Erythropoietin in Hemolytic Uremic Syndrome
erythropoietin - Hemolytic-Uremic Syndrome, Anemia
Phase 4CompletedHospital General de Niños Pedro de Elizalde242019-01-012021-01-13
Effect of Erythropoietin on Preterm Brain Injury
recombinant human erythropoietin - Premature Birth
Phase 4CompletedZhengzhou Children's Hospital, China4902009-01-012014-01-14
Erythropoietin and Platelet Activation Markers
erythropoietin - Thrombosis, Hypertension
Phase 4CompletedMedical University of Vienna122006-11-012011-07-14

Conditions studied

Anemia (2)  ·  Brain Injuries (1)  ·  Cerebral Palsy (1)  ·  Coitus (1)  ·  Hemolytic-Uremic Syndrome (1)  ·  Hypertension (1)  ·  Premature Birth (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Thrombosis (1)

Sponsors

Hospital General de Niños Pedro de Elizalde (1)  ·  Medical University of Vienna (1)  ·  Northwestern University (1)  ·  Piotr Czempik (1)  ·  Zhengzhou Children's Hospital, China (1)

Countries

Argentina (1)  ·  Austria (1)  ·  China (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Alejandro Balestracci, MD, PhD (1)  ·  Josh Levitsky, MD (1)  ·  Michael Wolzt, Prof. (1)

Results publications

PMID 22098110, PMID 33076939, PMID 35166922, PMID 39301879